New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 14, 2014
12:01 EDTRAX, VZ, XON, TMUS, GOOGL, FDX, DOW, DG, AZN, AMGN, FNSR, ALLY, MDLZThird Point gives quarterly update on stakes
NEW STAKES: Rackspace (RAX), Finisar (FNSR), Amgen (AMGN), Ally Financial (ALLY), and AstraZeneca (AZN). INCREASED STAKES: Dollar General (DG) and Dow Chemical (DOW). DECREASED STAKES: FedEx (FDX), Hertz (HTZ), T-Mobile (TMUS) and Intrexon (XON). LIQUIDATED STAKES: Google Class A (GOOGL), Verizon (VZ) and Mondelez (MDLZ).
News For RAX;ALLY;FNSR;AMGN;AZN;DG;DOW;FDX;GOOGL;TMUS;XON;VZ;MDLZ From The Last 14 Days
Check below for free stories on RAX;ALLY;FNSR;AMGN;AZN;DG;DOW;FDX;GOOGL;TMUS;XON;VZ;MDLZ the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | all recent news | >>
September 9, 2014
07:11 EDTTMUSUBM Tech to hold a conference
Subscribe for More Information
06:09 EDTVZVerizon CEO sees self-driving cars 3-5 years away, Detroit News reports
Subscribe for More Information
05:16 EDTVZ, TMUSSprint announces improved phone-trade in program, price match guarantee
Subscribe for More Information
September 8, 2014
16:18 EDTRAXOn The Fly: Closing Wrap
Subscribe for More Information
14:13 EDTAZNConnecticut AG tells FDA to speed up generic Nexium
A news release from the Connecticut Attorney General George Jepsen, dated September 4, says: In comments to a Citizen Petition filed with the FDA, Attorney General George Jepsen called on the federal agency to expeditiously end several years of delays preventing the sale of a generic form of the drug esomeprazole magnesium , esomeprazole, currently marketed under the brand name Nexium. Nexium is the second highest-selling pharmaceutical drug in the United States, and delays in approving generic versions have cost consumers and government healthcare payers billions of dollars. In his comments, Attorney General Jepsen alleges that an agreement between drug manufacturers Ranbaxy (RBXLY) and AstraZeneca Pharmaceuticals (AZN), Nexium’s brand-name manufacturer, has prevented other drug-makers from launching a generic version of the drug, ultimately harming all consumers by artificially inflating prices. Ranbaxy was first-to-file with the FDA for approval of a generic form of Nexium. AstraZeneca sued Ranbaxy for patent infringement, and the dispute was settled by an agreement that provided financial incentives for Ranbaxy to delay entry of its generic into the consumer market. Reference Link
13:26 EDTDGDollar General management to meet with Sterne Agee
Subscribe for More Information
11:24 EDTRAXRackspace trades higher following report CenturyLink in talks to buy company
Subscribe for More Information
10:58 EDTRAXCenturyLink would need to issue stock, raise debt to buy Rackspace, Re/code says
Following a Bloomberg report that said CenturyLink (CTL) is interested in buying Raxspace (RAX), Re/code's Arik Hesseldahl noted that CenturyLink has "practically no cash" and would have to issue stock and likely take on "significant debt" to make such an acquisition, though the author also noted that CenturyLink has a history of structuring such deals. However, Hesseldahl believes Rackspace remaining independent is still the "more likely scenario" than the company being bought. Reference Link
10:42 EDTFNSROptions with decreasing implied volatility
Options with decreasing implied volatility: KERX CONN CIEN INSM FNSR PAY PVH SWY
10:24 EDTRAXRackspace moves to resistance test on takeover speculation report
Bloomberg yesterday said in a report that sources indicated CenturyLink (CTL) was looking to acquire Rackspace Hosting (RAX). At the current price of $39.21, the stock is just under the $40 level which has been overhead resistance in the trading range in place since late last year. Support is at $38.28. A breakout above $40 would be bullish for future price.
09:12 EDTRAXOn The Fly: Pre-market Movers
Subscribe for More Information
08:58 EDTRAXRackspace risk/reward remains compelling, says Wells Fargo
Wells Fargo says that even with some takeout speculation being priced into Rackspace (RAX)shares today following reports that CenturyLink (CTL) is in talks to buy the company, the risk/reward on the stock remains compelling. Wells believes Rackspace either gets acquired at a premium or stays independent and announces a share buyback of $900M. The firm keeps an Outperform rating on the name.
08:36 EDTRAXRackspace Hosting volatility expected to move on acquisition report
Rackspace Hosting (RAX) volatility is expected to move on CenturyLink (CTL) looking to acquire says Bloomberg, citing sources. Overall option implied of 37 is below its 26-week average of 46 according to Track Data, suggesting decreasing price movement.
08:35 EDTDOWDow Chemical Chief Information Officer, Chief Sustainability Officer to retire
David E. Kepler, executive vice president, chief sustainability officer and chief information officer, has decided to retire at the end of this year. James R. Fitterling, vice chairman, Business Operations, will have executive oversight of Dow’s businesses including, Dow Packaging and Specialty Plastics, Dow Elastomers, Dow Electrical & Telecommunications, Polyurethanes, Epoxy, Specialty Chemicals, Chemicals, Hydrocarbons, and Energy. Fitterling will also continue to oversee implementation of the Company’s previously announced Chlorine, Chlorinated Organics, and Epoxy carve-out and divestment efforts. In addition, he will add to his responsibility for Supply Chain the following functions: Dow’s Business Services, which includes Information Systems and Workplace Services, Business Process Services, Purchasing, Customer Service, the Dow Services Business, and the Environmental Health & Safety and Sustainability organizations. Fitterling assumes this portion of his ne responsibilities from David E. Kepler, who has decided to retire from Dow following a 39-year career with the Company. Kepler most recently served as executive vice president, chief sustainability officer and chief information officer. Joe E. Harlan, chief commercial officer and vice chairman, Market Businesses, will have executive oversight for Dow’s market-driven businesses including, Agricultural Sciences, Dow Electronic Materials, Dow Pharma and Food Solutions, Home and Personal Care, Dow Automotive Systems, Dow Oil & Gas, Dow Microbial Control, Dow Water & Process Solutions, Dow Coating Materials, Performance Monomers, and Dow Building & Construction. Additionally, in his role as chief commercial officer he will drive Dow’s global Marketing and Sales strategy and organization. He will also maintain executive oversight of the Company’s presence in Asia Pacific.
08:31 EDTDOWDow Chemical CFO William Weideman to retire, Ungerleider to succeed as CFO
Subscribe for More Information
07:15 EDTAMGNIBC Life Sciences to hold a conference
10th Annual Cell Line Development & Engineering Conference to be held in Berkeley, California on September 8-10.
07:02 EDTAZNAstraZeneca announces availability of Bydureon pen 2mg
Subscribe for More Information
06:49 EDTAMGNAmgen shares to trend higher, price target to $150 at RBC Capital
RBC expects shares of Amgen to trend higher due to evolving sentiment around the 2015 pipeline and low multiple. Some investors want a break-up of the company to increase shareholder value but the analyst does not expect it to occur given the concentrated portfolio, tax reasons, and a commercial infrastructure that can not be split off. Shares are Outperform rated with a $150 price target, raised from $135.
05:35 EDTGOOGLGoogle added to Franchise Picks List at Jefferies
Jefferies added Google to its Franchise Picks List saying the company's YouTube division looks best positioned to benefit from growth in online video advertising, which the firm estimates could be a $17B opportunity by 2017 in the U.S. alone. Jefferies has a Buy rating on Google with a $700 price target.
05:28 EDTVZVerizon announces Verizon Auto Share
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use